The French suitor indicated it would be willing to pay about 34 euros per share, valuing Bilfinger at around 1.5 billion euros ($1.8 billion), according to the people. Bilfinger deemed the proposal too low and refused to grant due diligence to Altrad, the people said, asking not to be identified because the information is private.
Altrad wasn’t willing to improve its offer without receiving access ...
Learn more about Bloomberg Law or Log In to keep reading:
See Breaking News in Context
Bloomberg Law provides trusted coverage of current events enhanced with legal analysis.
Already a subscriber?
Log in to keep reading or access research tools and resources.